These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2157515)

  • 41. Reduced severity of Rh-haemolytic disease after anti-D immunoglobulin.
    Derrick Tovey LA; Robinson AE
    Br Med J; 1975 Nov; 4(5992):320-2. PubMed ID: 811308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rho(D) immunoglobulin (RhoGAM): how it came into being.
    Hamilton EG
    Obstet Gynecol; 1991 Jun; 77(6):957-8. PubMed ID: 1851547
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
    Freda VJ; Gorman JG; Pollack W; Bowe E
    N Engl J Med; 1975 May; 292(19):1014-6. PubMed ID: 804134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rhesus immunoprevention by means of immunoglobulin anti-D].
    Maas DH; Schneider
    Med Monatsschr; 1975 Aug; 29(8):340-7. PubMed ID: 813106
    [No Abstract]   [Full Text] [Related]  

  • 45. Controlling Rh haemolytic disease of the newborn in India.
    Joseph KS
    Br J Obstet Gynaecol; 1991 Apr; 98(4):369-77. PubMed ID: 1851635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
    Harkness M; Freer Y; Prescott RJ; Warner P
    Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 48. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Our experience in the prevention of Rh immunization with immunoglobulin anti-D].
    Coletta A; Belletti F; Cardona A; Cammarota M; De Ninno F; Pennino G; Toro L; Miceli G
    Minerva Ginecol; 1974 Jul; 26(7):404-6. PubMed ID: 4213550
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of Rh immunization in Germany.
    Schneider J
    Pathologica; 1972; 64(929):105-9. PubMed ID: 4210234
    [No Abstract]   [Full Text] [Related]  

  • 51. Sound boards. Rh immunoprophylaxis: is antepartum therapy desirable?
    Nusbacher J; Bove JR
    N Engl J Med; 1980 Oct; 303(16):935-7. PubMed ID: 6774249
    [No Abstract]   [Full Text] [Related]  

  • 52. [Preventive treatment of hemolytic disease of the newborn by use of anti-Rh(D) immunoglobulins].
    Vavrik R; Skorczyński M; Skrzypulec Z
    Akush Ginekol (Mosk); 1968 Oct; 44(10):24-6. PubMed ID: 5760959
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prevention of isoimmunization Rh in Italy].
    Dambrosio F
    Pathologica; 1972; 64(929):119-34. PubMed ID: 4210236
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial: Prevention of rhesus immunization in Australia.
    Med J Aust; 1975 Aug; 2(7):241. PubMed ID: 808696
    [No Abstract]   [Full Text] [Related]  

  • 55. Antenatal prophylaxis with anti-D immunoglobulin.
    BMJ; 1989 Oct; 299(6704):919-20. PubMed ID: 2555002
    [No Abstract]   [Full Text] [Related]  

  • 56. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
    Barlow JF
    S D J Med; 1999 Jan; 52(1):7-8. PubMed ID: 9926725
    [No Abstract]   [Full Text] [Related]  

  • 57. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of haemolytic diseases of the newborn due to anti-D.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6265):676-7. PubMed ID: 6781610
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indications for and efficacy of a low-dose of anti-D immunoglobulin].
    Bellati U; Morici A; Riccardi P; Serri FG; Garzetti GG
    Minerva Ginecol; 1977 Feb; 29(2):91-4. PubMed ID: 404598
    [No Abstract]   [Full Text] [Related]  

  • 60. Preventing Rh haemolytic disease.
    Tovey D
    Br Med J; 1978 Sep; 2(6142):952-3. PubMed ID: 101268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.